Morris Misel delivering keynote on Amazon Pharmacy and the future of pharmacy to healthcare leaders at a conference, discussing vertical integration and healthcare strategy in the US and Australia

Amazon Pharmacy, Vertical Integration, and the Re-Architecture of Trust

What Amazon’s Expansion Means for the Future of Pharmacy in the US and Australia

Amazon has expanded same-day prescription delivery across thousands more US cities.

By the end of 2026, it plans to cover roughly 4,500 locations. It has integrated pharmacy services into its primary care network, One Medical. It is trialling in-clinic kiosks so patients can collect common medications immediately after their appointment.

Diagnosis.
Prescription.
Payment.
Fulfilment.

Compressed into one ecosystem.

This is not just a retail move.

It is the redesign of the prescription pathway.

And whether you operate in the United States or Australia, that matters.


What Is Actually Happening

Amazon Pharmacy emerged after the acquisition of PillPack in 2020. Since then, it has layered in:

  • Home delivery of branded and generic medications

  • Subscription-style pricing for many generics

  • 24/7 digital pharmacist access

  • Integration with One Medical clinics

  • In-clinic prescription kiosks

  • Rapid expansion of same-day prescription delivery

According to recent reporting in Fast Company, Amazon’s same-day service expansion significantly increases its geographic footprint in the US.

This matters in a country where pharmacy access is uneven. Tens of millions of Americans live in areas commonly described as pharmacy deserts, where store closures or geography limit access to medicines.

At the same time:

  • Major retail pharmacy chains are closing stores

  • Pharmacy Benefit Managers, the intermediaries between insurers, manufacturers and pharmacies, face growing scrutiny

  • Margins are tightening

  • Telehealth has normalised digital consultation

The US pharmacy ecosystem is under structural strain.

In Australia, the model differs.

Community pharmacy ownership rules, dispensing regulations and the Pharmaceutical Benefits Scheme create a more tightly regulated framework. The Pharmacy Guild of Australia has historically played a strong advocacy role in maintaining that structure.

But structural difference does not mean immunity from platform logic.

Because what Amazon is doing is not simply selling medicines.

It is collapsing friction.


The Friction Question

Healthcare systems, especially pharmacy systems, are built around handoffs.

Doctor to pharmacist.
Script to dispensing bench.
Insurance approval to collection.
Patient to queue.

Each handoff introduces time, cost and administrative complexity.

Amazon’s model aims to reduce those handoffs.

When a patient visits a One Medical clinic, the prescription can be processed within the same ecosystem. Some medications can be dispensed immediately. Others are delivered rapidly via an existing logistics network built originally for retail.

From a patient perspective, this feels like convenience.

From a systems perspective, it is vertical integration.

And vertical integration changes power.


I Have Been Watching This Arc for Decades

More than twenty years ago, I stood in front of a room of pharmacy owners and told them they were the most expensive pickers and packers on earth.

You could hear the silence land.

I said repetitive dispensing tasks would eventually be automated. That robots and systems would take over predictable behind-the-counter work. That raised counters separating pharmacist and patient symbolised a model that would need to evolve.

I suggested the long-term value of pharmacy would sit less in product handling and more in trusted advice, preventative care, and patient familiarity.

I warned that front-of-shop monopolies and retail cross-subsidies would not last indefinitely.

It was uncomfortable.

And yet, they kept inviting me back.

For more than twenty years.

Not because I was right about every detail.

But because the direction of travel was visible.

Amazon’s expansion is not a surprise moment.

It is a continuation.


This Is Not Disruption. It Is Re-Architecture.

The word disruption is used too loosely.

What is happening in pharmacy is structural re-architecture.

If one organisation controls:

  • The appointment booking

  • The clinical consultation

  • The prescribing software

  • The payment channel

  • The fulfilment logistics

  • The refill algorithm

It is not merely competing on convenience.

It is shaping the operating model of healthcare access.

In the United States, where retail pharmacy chains are retrenching and access gaps are widening, this has immediate competitive implications.

In Australia, regulatory guardrails slow the pace, but the architectural logic remains relevant.

Platform thinking eventually pressures every regulated sector.


The Ripple Effects of Collapsing Friction

When friction disappears in one part of a system, ripple effects follow.

1. Workforce Evolution

Pharmacy work decomposes into tasks.

Dispensing.
Checking.
Counselling.
Inventory management.
Data handling.

Some of these tasks are increasingly automated. Some are enhanced by AI. Some remain deeply human.

This is where my HUMAND framework becomes practical. Work is no longer defined only by job titles, but by the most effective blend of Human, Machine and AI capability.

Pharmacies that consciously redesign around clinical advisory value will strengthen.

Those anchored purely in throughput will feel pressure.

2. Trust Reallocation

Healthcare runs on trust.

Historically, that trust was local. The familiar pharmacist. The known face in the community.

Platform models shift trust from personal familiarity to system reliability.

Same-day delivery. Transparent pricing. Digital pharmacist access.

Neither anchor is inherently better.

But the centre of gravity moves.

Leaders must decide deliberately where trust will sit in their own model.

3. Data Concentration

Integrated ecosystems accumulate behavioural insight.

Refill timing.
Adherence patterns.
Chronic condition flows.

When combined with AI, this data becomes strategic infrastructure.

The competitive question becomes clear:

Who owns the insight layer of healthcare?

Store footprint matters.

But insight ownership may matter more.


US and Australia: Different Systems, Shared Signals

In the United States, the pressure is immediate.

Pharmacy deserts. PBM reform. Retail closures. Telehealth expansion. Consumer expectations shaped by real-time logistics.

In Australia, ownership and dispensing regulations provide structural protection.

But consumer expectations do not respect borders.

Patients accustomed to frictionless services in banking, retail and travel will eventually expect similar convenience in healthcare.

The signal is not that Amazon will replicate the US model in Australia tomorrow.

The signal is that infrastructure logic is entering healthcare globally.

Infrastructure shifts are gradual.

Until they are not.


The Leadership Question

This is not a battle between Amazon and community pharmacy.

That framing is too narrow.

The real questions are:

Where are the friction points in your system?
Who could collapse them?
If a logistics platform can move upstream into clinical pathways, what does that say about the stability of your operating model?

Strategic foresight is not about panic.

It is about preparation.

You cannot predict the future.

But you can prepare for it.


Why This Belongs on Your Stage in 2026

Amazon Pharmacy’s expansion is a signal.

But the deeper conversation is about:

  • Vertical integration in healthcare

  • The future of pharmacy workforce design

  • AI and task evolution in regulated sectors

  • Trust and data ownership

  • Platform logic entering protected industries

  • Strategic preparation in association-led ecosystems

I have been part of the pharmacy and healthcare conversation for over two decades, challenging assumptions, identifying signals early, and helping leaders prepare rather than react.

The architecture is shifting faster now.

If you lead in pharmacy, healthcare, insurance or policy, this is not peripheral news.

It is the operating environment changing.

If this conversation needs to be on your stage, in your boardroom or inside your strategic planning sessions in 2026, let’s talk.

Visit https://morrismisel.com to discuss keynote and advisory availability.

Choose Forward.


#AmazonPharmacy #FutureOfPharmacy #HealthcareLeadership #PharmacyGuildAustralia #CommunityPharmacy #HealthcareStrategy #HealthcareInnovation #VerticalIntegration #HealthcareTransformation #PharmacyIndustry #HealthPolicy #PBMReform #PharmacyDeserts #AIinHealthcare #DigitalHealth #HealthTech #HealthcareWorkforce #StrategicForesight #HealthcareBoards #AssociationLeadership #HealthcareConferences #HealthcareSpeakers #USHealthcare #AustralianHealthcare #ChooseForward

Leave a comment